Fig. 1

Epitope-HLA docking results visualized using Discovery Studio software. (A) NIADINLIY epitope and its corresponding MHC allele (HLA-B*35:01), (B) NSPDLKAQY epitope and its corresponding MHC allele (HLA-A*26:01), (C) STGRASLTY epitope and its corresponding MHC allele (HLA-A*01:01), (D) positive control epitope and its corresponding MHC allele (HLA-B*15:01), (E) negative control epitope and its corresponding MHC allele (HLA-B*15:01), (F) ISEAMSIDMNVLAKI epitope and its corresponding MHC allele (HLA-DRB1*03:01), (G) IKKFKFGAASVLIGI epitope and its corresponding MHC allele (HLA-DRB1*01:01), (H) LIVLEQGFTAKYVFR epitope and its corresponding MHC allele (HLA-DRB1*01:01), (I) WRSFLNKVKSLRILN positive control epitope and its corresponding MHC allele (DRB1*04:01), (J) KPTGAGPKDNGGACG negative control epitope and its corresponding MHC allele (DRB1*04:01).